Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centers

Authors

Peter May (ORCID: https://orcid.org/0000-0002-9045-0595)
Johannes Jung (ORCID: https://orcid.org/0000-0003-0137-7929)
Ralph Wäsch
Sebastian Theurich (ORCID: https://orcid.org/0000-0001-5706-8258)
Florian C. Bassermann (ORCID: https://orcid.org/0000-0003-4435-2609)
Monika Martha Engelhardt (ORCID: https://orcid.org/0000-0003-0405-1676)
Burkhard Schmidt (ORCID: https://orcid.org/0000-0001-7394-2742)
Michael Rassner (ORCID: https://orcid.org/0000-0003-0964-9511)
Wajma Shahbaz
Marion Hoegner

Institutions

University of Freiburg (DE)
German Cancer Research Center (DE)
Heidelberg University (DE)
University Medical Center Freiburg (DE)
University Hospital Heidelberg (DE)
Comprehensive Cancer Center Mainfranken (DE)
Medical Genetics Center (DE)
Universitätsmedizin Göttingen (DE)
Cancer Research Center (US)
Comprehensive Blood & Cancer Center (US)
Centro de Investigación del Cáncer (ES)
Technical University of Munich (DE)
Ludwig-Maximilians-Universität München (DE)

Publication Details

Journal: Haematologica
Published: 2025-10-16
DOI: https://doi.org/10.3324/haematol.2025.288320
Citations: 1
Primary Topic: Multiple Myeloma Research and Treatments
Type: article
Field-Weighted Citation Impact: 1.77

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centers

Peter May, Johannes Jung, Ralph Wäsch, Sebastian Theurich et al.

Oct 16, 2025

1 citations

Haematologica

Multiple Myeloma Research and Treatments

1.77

article

Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centers

Peter May, Johannes Jung, Ralph Wäsch, Sebastian Theurich, Florian C. Bassermann, Monika Martha Engelhardt, Burkhard Schmidt, Michael Rassner, Wajma Shahbaz, Marion Hoegner

October 16, 2025article en

1 citations

Abstract

No abstract available for this paper.

Haematologica

University of Freiburg (DE), German Cancer Research Center (DE), Heidelberg University (DE), University Medical Center Freiburg (DE), University Hospital Heidelberg (DE), Comprehensive Cancer Center Mainfranken (DE), Medical Genetics Center (DE), Universitätsmedizin Göttingen (DE), Cancer Research Center (US), Comprehensive Blood & Cancer Center (US), Centro de Investigación del Cáncer (ES), Technical University of Munich (DE), Ludwig-Maximilians-Universität München (DE)

Openalex Percentile: Top 12%

Multiple Myeloma Research and Treatments

1.77

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.